Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07866404Active, not recruiting
Randomised, open-label trial in multivessel coronary artery disease (MVD) (2 arms), sponsored by Chaudhry Pervaiz Elahi Institute of Cardiology. Primary endpoint: Major Adverse Cardiovascular Events at 12 months. Started Jul 2025; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07866404.